Region: Global
Category: Diagnostics

Global Diagnostics

(7,204 reports matching your criteria)
  • Rabies Diagnostics

    ... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end of ... Read More

  • Mammography Equipment

    ... CAGR of 6.8% over the analysis period 2024-2030. 2-D Digital Mammography Systems, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.1 Billion by the end of ... Read More

  • Cholesterol Testing

    ... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More

  • DNA Probes-Based Diagnostics

    ... at a CAGR of 9.4% over the analysis period 2024-2030. Infectious Diseases, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$20.4 Billion by the end of ... Read More

  • Electrophoresis Equipment and Supplies

    ... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$1.2 Billion by ... Read More

  • Spectroscopy Equipment and Accessories

    ... 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Molecular Spectroscopy, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$7.6 Billion by the ... Read More

  • Titrators (Automatic and Manual)

    ... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Coulometric, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$334.3 Million by the end ... Read More

  • Computed Tomography (CT) Scanners

    ... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. High-End Slice, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.5 Billion by the ... Read More

  • Hematology Instruments and Reagents

    ... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hematology Analyzers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the ... Read More

  • Heavy Metal Testing

    ... at a CAGR of 4.7% over the analysis period 2024-2030. Arsenic, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.1 Billion by the end of the ... Read More

  • PET-CT Scanners

    ... CAGR of 5.0% over the analysis period 2024-2030. Stationary, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.6 Billion by the end of the analysis period. ... Read More

  • Microtomes

    ... 6.0% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$162.8 Million by the end of the analysis period. Growth in ... Read More

  • Tuberculosis Testing

    ... CAGR of 4.9% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.4 Billion by the end of the analysis period. ... Read More

  • Veterinary Hematology Analyzers

    ... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More

  • Veterinary Molecular Diagnostics

    ... at a CAGR of 7.5% over the analysis period 2024-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$342.8 Million by the end ... Read More

  • Lung Cancer Diagnostics

    ... at a CAGR of 7.8% over the analysis period 2024-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.3 Billion by the end of ... Read More

  • COVID-19 Testing

    ... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More

  • STD Testing

    ... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More

  • Blood Group Typing

    ... at a CAGR of 9.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$2.8 Billion by the end of the ... Read More

  • Automated and Rapid Microbiological Tests

    ... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical), one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 Billion ... Read More

  • Cardiac Biomarkers

    ... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More

  • Aptamers

    ... 15.7% over the analysis period 2024-2030. DNA Aptamers, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$227.5 Million by the end of the analysis period. Growth ... Read More

  • Autoimmune Disease Diagnosis

    ... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More

  • Automated Blood Tube Labelers and Specimen Transport Boxes

    ... 2024, is expected to reach US$518.8 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 7.4% ... Read More

  • Bio-MEMS Devices

    ... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings